Filing Details

Accession Number:
0001181431-11-047818
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-02 10:50:05
Reporting Period:
2011-08-31
Filing Date:
2011-09-02
Accepted Time:
2011-09-02 10:50:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219837 T David Gibbons C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-31 12,000 $95.31 30,002 No 4 S Direct
Common Stock Acquisiton 2011-08-31 17,500 $18.18 47,502 No 4 M Direct
Common Stock Disposition 2011-08-31 17,500 $95.49 3,002 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option RIght to Buy Disposition 2011-08-31 17,500 $0.00 35,000 $18.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2007-03-31 2014-03-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13 Indirect By Profit Sharing
Footnotes
  1. The price in column 4 is a weighted average. The prices actually received ranged from $95.23 to $95.50. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  2. The price in column 4 is a weighted average. The prices actually received ranged from $95.41 to $95.69. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.